Omega Diagnostics Group PLC Closure of Omega Diagnostics GmbH (8614M)
May 02 2018 - 1:41AM
UK Regulatory
TIDMODX
RNS Number : 8614M
Omega Diagnostics Group PLC
02 May 2018
Omega Diagnostics Group PLC
("Omega" or "the Company" or the "Group")
Closure of Omega Diagnostics GmbH
Omega (AIM: ODX), the medical diagnostics company focused on
allergy, food intolerance and infectious disease, announces the
closure of Omega Diagnostics GmbH ("Omega GmbH").
Further to the announcement on 10 April 2018, the Board has not
been able to conclude any transaction for a sale of Omega GmbH. The
Board has therefore decided to initiate insolvency proceedings
through the German court system, as soon as practically possible,
under the guidance of its legal advisers. The contingent cost
associated with this closure is not expected to be more than
GBP0.45m and could be significantly less than this figure.
For the year ended 31 March 2018, Omega GmbH had sales of
approximately EUR3.2 million* and incurred an EBITDA loss of
approximately EUR0.4 million*.
The information communicated in this announcement is inside
information for the purposes of Article 7 of EU Regulation
596/2014.
* Figures for the year ended 31 March 2018 are unaudited as at
the date of this release.
Contacts:
Omega Diagnostics Group Tel: 01259 763 030
PLC
Colin King, Chief Executive www.omegadiagnostics.com
Kieron Harbinson, Group
Finance Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/James Thompson
(Corporate Finance)
Camille Gochez/ Abigail
Wayne (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or
omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSSUSMEFASEDI
(END) Dow Jones Newswires
May 02, 2018 02:41 ET (06:41 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024